Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress.

Zhou MS, Jaimes EA, Raij L.

Hypertension. 2004 Aug;44(2):186-90. Epub 2004 Jul 6.

2.

Combination therapy of amlodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension.

Zhou MS, Tian R, Jaimes EA, Raij L.

Am J Hypertens. 2014 Jun;27(6):873-80. doi: 10.1093/ajh/hpt272. Epub 2014 Jan 11.

PMID:
24413709
3.

In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II.

Zhou MS, Adam AG, Jaimes EA, Raij L.

Hypertension. 2003 Nov;42(5):945-51. Epub 2003 Sep 15.

4.

Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability.

Zhou MS, Schuman IH, Jaimes EA, Raij L.

Am J Physiol Renal Physiol. 2008 Jul;295(1):F53-9. doi: 10.1152/ajprenal.00041.2008. Epub 2008 May 7.

6.

Atorvastatin improves sodium handling and decreases blood pressure in salt-loaded rats with chronic renal insufficiency.

Juncos LI, Martín FL, Baigorria ST, Pasqualini ME, Fiore MC, Eynard AR, Juncos LA, García NH.

Nutrition. 2012 Sep;28(9):e23-8. doi: 10.1016/j.nut.2012.02.008. Epub 2012 Jun 12.

PMID:
22698702
7.

HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.

Wassmann S, Laufs U, Bäumer AT, Müller K, Ahlbory K, Linz W, Itter G, Rösen R, Böhm M, Nickenig G.

Hypertension. 2001 Jun;37(6):1450-7.

8.

Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS/iNOS imbalance in rat aorta.

Gong X, Ma Y, Ruan Y, Fu G, Wu S.

Exp Gerontol. 2014 Apr;52:9-17. doi: 10.1016/j.exger.2014.01.015. Epub 2014 Jan 21.

PMID:
24463049
9.

Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats.

Okamura T, Tawa M, Geddawy A, Shimosato T, Iwasaki H, Shintaku H, Yoshida Y, Masada M, Shinozaki K, Imamura T.

J Pharmacol Sci. 2014;124(1):76-85. Epub 2013 Dec 27.

10.

Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.

Beckman JA, Liao JK, Hurley S, Garrett LA, Chui D, Mitra D, Creager MA.

Circ Res. 2004 Jul 23;95(2):217-23. Epub 2004 Jun 3.

11.

Effect of demethylasterriquinone b1 in hypertension associated vascular endothelial dysfunction.

Shah DI, Singh M.

Int J Cardiol. 2007 Sep 3;120(3):317-24. Epub 2007 Jan 22.

PMID:
17240464
12.

Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.

Briones AM, Rodríguez-Criado N, Hernanz R, García-Redondo AB, Rodrigues-Díez RR, Alonso MJ, Egido J, Ruiz-Ortega M, Salaices M.

Hypertension. 2009 Jul;54(1):142-9. doi: 10.1161/HYPERTENSIONAHA.109.133710. Epub 2009 May 18.

13.

Atorvastatin restores endothelial function in offspring of protein-restricted rats in a cholesterol-independent manner.

Torrens C, Kelsall CJ, Hopkins LA, Anthony FW, Curzen NP, Hanson MA.

Hypertension. 2009 Apr;53(4):661-7. doi: 10.1161/HYPERTENSIONAHA.108.122820. Epub 2009 Feb 16.

14.

Atorvastatin ameliorates cardiac fibrosis and improves left ventricular diastolic function in hypertensive diastolic heart failure model rats.

Akahori H, Tsujino T, Naito Y, Matsumoto M, Sasaki N, Iwasaku T, Eguchi A, Sawada H, Hirotani S, Masuyama T.

J Hypertens. 2014 Jul;32(7):1534-41; discussion 1541. doi: 10.1097/HJH.0000000000000184.

PMID:
24759122
15.

Atorvastatin ameliorates arsenic-induced hypertension and enhancement of vascular redox signaling in rats.

Sarath TS, Waghe P, Gupta P, Choudhury S, Kannan K, Pillai AH, Harikumar SK, Mishra SK, Sarkar SN.

Toxicol Appl Pharmacol. 2014 Nov 1;280(3):443-54. doi: 10.1016/j.taap.2014.08.032. Epub 2014 Sep 11.

PMID:
25218292
16.
17.

The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.

Rakotoniaina Z, Guerard P, Lirussi F, Goirand F, Rochette L, Dumas M, Bardou M.

Naunyn Schmiedebergs Arch Pharmacol. 2006 Dec;374(3):195-206. Epub 2006 Nov 11.

PMID:
17102939
18.

Anti-oxidant effects of atorvastatin in dexamethasone-induced hypertension in the rat.

Mondo CK, Yang WS, Zhang N, Huang TG.

Clin Exp Pharmacol Physiol. 2006 Nov;33(11):1029-34.

PMID:
17042910
20.

Nitric oxide synthase activity and renal injury in genetic hypertension.

Hayakawa H, Raij L.

Hypertension. 1998 Jan;31(1 Pt 2):266-70.

Supplemental Content

Support Center